Navigation Links
Herceptin Again Proves Mettle Against Breast Cancer
Date:1/28/2010

Improved survival seen when used with chemo for HER2 malignancies, researchers report

THURSDAY, Jan. 28 (HealthDay News) -- High-risk breast cancer patients with HER2-positive tumors benefit from receiving the targeted therapy Herceptin while undergoing chemotherapy, new research shows.

"It's in a European journal [The Lancet], but it's something many of us in the U.S. have already begun to do," said Dr. Jay Brooks, chairman of hematology/oncology at Ochsner Health System in Baton Rouge, La. "It just confirms what has really become standard of care in this country, but it's very nice to see it done in a scientific way," he added.

"The reason why Herceptin is so valuable to patients who have locally advanced breast cancer is they have a very bad prognosis," he continued. "The cancers are usually bigger. They may have spread to the lymph nodes in the armpits and they're usually not small enough to be cut out to preserve the breast."

When Brooks sees a patient with locally advanced breast cancer, he treats them first with chemotherapy, to shrink the tumor, along with trastuzumab (Herceptin). Once chemo is completed -- after about six months -- it's easier to operate and remove the tumor. Then the patient is continued on Herceptin for a year, followed by radiation.

The new study, one of the largest looking at Herceptin in this context, was funded by Hoffmann-La Roche, which makes the drug. It appears in the Jan. 30 issue of The Lancet.

Previous research has shown that Herceptin with chemotherapy helped women with both early and metastatic breast cancer live longer.

According to the study authors, from IRCCS Istituto Nazionale de Tumori in Milan, about 22 percent of early breast cancers, 35 percent of locally advanced breast cancers and metastatic tumors, and 40 percent of inflammatory breast cancers overexpress HER2 (human epidermal growth factor receptor-2). These tumors tend to be
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Herceptin helps women with multiple chromosomes containing HER2 gene, study finds
2. Xeloda(R), Taxotere(R) and Herceptin(R) Combination Study Suggests Clinical Benefit in Invasive Breast Cancer with Shortened Treatment Cycle
3. If Herceptin is Approved in Combination With Other Emerging Therapies it Will be in a Position to Retain Patient Share From Tykerb/Tyverb for the Treatment of HER2-Positive Breast Cancer
4. Mathematical modeling predicts response to Herceptin
5. Routine Testing Would Improve Herceptin Use in Breast Cancer
6. Biosimilars of Rituxan, MabThera, Herceptin and Erbitux will Erode $8.2 Billion in U.S. and European Sales in 2018
7. Chemo With Herceptin May Be Best for Some Breast Cancers
8. Mayo Clinic researchers say breast cancer survival improves Herceptin used with chemotherapy
9. DNA vaccine against multiple sclerosis appears safe, potentially beneficial
10. Antioxidants show no clear benefit against cardiovascular events, death in high-risk women
11. Despite overeating, morbidly obese mice gain protection against diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 2014 Power morcellator lawsuits ( http://www.gynecaremorcellatorlawsuit.com/ ... behalf of women who allegedly experienced the spread of ... reports. According to court documents, one of the most ... U.S. District Court, Northern District of New York, on ... of a power morcellator manufactured Karl Storz Endoscopy - ...
(Date:8/27/2014)... What’s next for 14 year old Sriram Hathwar, ... Spelling Bee? Sririam will visit Philadelphia on Friday, August ... Eye Hospital.     , The teen from Painted Post, New ... , Wills Eye Ophthalmologist-in-Chief, Dr. Julia Haller will show ... diagnostic testing. He will also tour historic Philadelphia ...
(Date:8/27/2014)... The newest Abington Health Center ... 8, 2014. This new 15,000 square foot, $5 million ... care practices and walk-in laboratory services. , ... endeavor for Abington Health as the healthcare landscape changes,” ... “Establishing a location in Lower Gwynedd allows us to ...
(Date:8/27/2014)... -- Overconfident people are better at convincing others that ... are more likely to get promotions and reach high-level ... that these "self-deceived" people are also more likely to ... And finally, people who underestimate themselves are regarded ... British researchers. Their findings were published Aug. 27 in ...
(Date:8/27/2014)... Recent growth in health care spending for commercially ... for medical services, rather than increased use, according to ... Institute for Health Policy & Clinical Practice, published in ... Managed Care . , There is increasing concern that ... increased prices faced by payers and, ultimately, consumers," said ...
Breaking Medicine News(10 mins):Health News:Power Morcellator Lawsuit Alleges Storz Morcellator Caused Spread of Aggressive Uterine Cancer, Bernstein Liebhard LLP Reports 2Health News:Power Morcellator Lawsuit Alleges Storz Morcellator Caused Spread of Aggressive Uterine Cancer, Bernstein Liebhard LLP Reports 3Health News:Power Morcellator Lawsuit Alleges Storz Morcellator Caused Spread of Aggressive Uterine Cancer, Bernstein Liebhard LLP Reports 4Health News:Scripps National Spelling Bee Co-Champion and Aspiring Ophthalmologist Coming to Wills Eye Hospital in Philadelphia 2Health News:Abington Health Opens New Health Center in Lower Gwynedd 2Health News:Overconfident Folks May Blind Others to Their Real Abilities 2Health News:Tracking spending among the commercially insured 2
... Lancet Neurology says that the fact that first-borns have a ... myth. Birth order of the children does not increase their ... // have any affect on the incidence of multiple sclerosis., ... a role in MS. Previous research has reported a higher ...
... A new study indicates that a combination of surgery ... patients suffering from spinal cord compression. //, ,Metastatic ... common complication of cancer, occurring in 5 to 14 ... of corticosteroids and radiotherapy - after which only 50 ...
... also been under intense scrutiny to look at their ... and 25 other related conditions) and HIV. // , ... lover of all, Casanova in the 17th century was ... against infection. The question now is that how much ...
... the genetic pathway involved in the development of hearing. Research ... ear –– the cells largely responsible for hearing // ... ,Situated in the hearing portion of the inner ... the ear in the form of sound waves into chemical ...
... claimed at least 20 lives in the past two weeks ... already present in the neighboring Indian state of UP // ... 10 deaths each in the townships of Tikapur and Dhangadi ... 80 patients were undergoing treatment in various hospitals and health ...
... slowly spreading in UP and causing more deaths especially in ... caused by the rapidly spreading killer virus // in ... disease was so far confined largely to Gorakhpur and neighboring ... only nearby Bahraich, Barabanki and Lakhimpur-Kheri districts but also to ...
Cached Medicine News:Health News:"An Armour against pleasure, and a cobweb against infection" – Has the condom withstood the test of time 2Health News:"An Armour against pleasure, and a cobweb against infection" – Has the condom withstood the test of time 3Health News:"An Armour against pleasure, and a cobweb against infection" – Has the condom withstood the test of time 4Health News:Encephalitis Claims 131 lives in Uttar Pradesh 2
(Date:8/27/2014)... -- Ambit Biosciences (Nasdaq: AMBI ), a biopharmaceutical company ... in oncology, autoimmune and inflammatory disease, today announced the Company,s ... held at The New York Palace Hotel in ... Alan Fuhrman , Ambit,s CFO, will provide an ... at 1:10 p.m. ET on Wednesday, September 3, 2014.  The ...
(Date:8/27/2014)... Aug. 27, 2014  After the February 2014 launch ... billing solution for medical practices and management companies, ... the new software. "The feedback has been ... . "The sheer number of demos and new sign-ups ... was for these types of software features." ...
(Date:8/27/2014)... , Aug. 27, 2014  Zimmer Holdings, Inc. (NYSE ... announced that it will be participating in the Morgan ... in New York, New York , ... President and CEO of Zimmer, will be presenting at ... and CEO of Biomet, will join Mr. Dvorak for ...
Breaking Medicine Technology:Ambit Announces Participation At Baird 2014 Health Care Conference 2Medical Software Company, Prime Clinical Systems, Sees Excellent Response to their Workers' Compensation Solutions 2Medical Software Company, Prime Clinical Systems, Sees Excellent Response to their Workers' Compensation Solutions 3
... PHILADELPHIA, Oct. 5 GlaxoSmithKline [NYSE: GSK] today ... Administration,s (FDA) Oncologic Drugs Advisory Committee (ODAC) voted ... (pazopanib). Specifically, the panel voted that the benefit-to-risk ... cell carcinoma (RCC). Pazopanib is an investigational, oral ...
... PALO ALTO, Calif., Oct. 5 PEAK Surgical, Inc. ... an agreement that grants the Surgical Technologies business at ... the PEAK PlasmaBlade® TnA (Tonsil and Adenoid) tissue dissection ... , "PEAK,s agreement with Medtronic is a major ...
Cached Medicine Technology:GlaxoSmithKline Receives Unanimous FDA Panel Approval Recommendation for VOTRIENT(TM) 2GlaxoSmithKline Receives Unanimous FDA Panel Approval Recommendation for VOTRIENT(TM) 3PEAK Surgical and Medtronic Announce Global Distribution Agreement for the Ear, Nose, and Throat Market 2PEAK Surgical and Medtronic Announce Global Distribution Agreement for the Ear, Nose, and Throat Market 3
Liquichek Pediatric Control is a product designed to monitor important analytes for neonatal testing. This control monitors four bilirubin parameters at two clinically significant levels....
... Chemistry Control (Human) provides a comprehensive ... enzymes and CO2. It requires no ... most major instruments and methodologies. Available ... fill sizes (10 mL fill size ...
Liquid Assayed and Unassayed Multiqual Controls are comprehensive, liquid, human serum based chemistry controls, available in three levels....
Lyphochek® Drug Free Serum can serve as a drug-free baseline for HPLC analysis or as a negative control....
Medicine Products: